World Health Organization systematic review of screening tests for preeclampsia

Obstetrics and Gynecology

Volumn 104, Issue 6, 2004, Pages 1367-1391

  Conde Agudelo, Agustin ^b   Villar, José ^a   Lindheimer, Marshall ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; KALLIKREIN; PEPTIDE;

ANTIBODY TITER; CASE CONTROL STUDY; COHORT ANALYSIS; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DOPPLER ECHOGRAPHY; EMBASE; EVALUATION; HIGH RISK POPULATION; HUMAN; MEDICAL LITERATURE; MEDLINE; METHODOLOGY; PEPTIDE ANALYSIS; PREDICTION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROBABILITY; QUALITY CONTROL; RECEIVER OPERATING CHARACTERISTIC; REVIEW; RISK ASSESSMENT; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; SYSTEMATIC REVIEW; URINE LEVEL; WORLD HEALTH ORGANIZATION; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; DOPPLER FLOWMETRY; ECHOGRAPHY; FEMALE; HIGH RISK PREGNANCY; META ANALYSIS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; URINE; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE;

BLOOD PRESSURE MONITORING, AMBULATORY; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; KALLIKREINS; OXIDATIVE STRESS; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY, HIGH-RISK; RESEARCH DESIGN; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, PRENATAL; VASCULAR RESISTANCE; WORLD HEALTH ORGANIZATION;

EID: 14644415397     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000147599.47713.5d     Document Type: Review

References (119)

1. Conde-Agudelo A, Belizan JM, Diaz-Rossello JL. Epidemiology of fetal death in Latin America. Acta Obstet Gynecol Scand 2000;79:371-8.
2. Villar J, Say L, Gülmezoglu M, Merialdi M, Lindheimer M, Betran AP, et al. Eclampsia and preeclampsia: a worldwide health problem for 2000 years. In: Critchley H, MacLean A, Poston L, Walker J, editors. Preeclampsia. London: RCOG Press; 2003. p. 189-207.
3. Roberts JM, Cooper DW. Pathogenesis and genetics of preeclampsia [review]. Lancet 2001;357:53-6.
4. Dekker GA, Sibai BM. Early detection of preeclampsia [review]. Am J Obstet Gynecol 1991;165:160-72.
5. O'Brien WF. The prediction of preeclampsia [review]. Clin Obstet Gynecol 1992;35:351-64.
6. Conde-Agudelo A, Lede R, Belizan J. Evaluation of methods used in the prediction of hypertensive disorders of pregnancy [review]. Obstet Gynecol Surv 1994;49:210-22.
7. Myatt L, Miodovnik M. Prediction of preeclampsia [review]. Semin Perinatol 1999;23:45-57.
8. Visser W, Wallenburg HC. Prediction and prevention of pregnancy-induced hypertensive disorders [review]. Baillieres Best Pract Res Clin Obstet Gynaecol 1999;13:131-56.
9. Irwig L, Tosteson AN, Gatsonis C, Lau J, Colditz G, Chalmers TC, et al. Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med 1994;120:667-76.
10. Jaeschke R, Guyatt G, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 1994;271:389-91.
11. Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 1994;271:703-7.
12. Cochrane Methods Group on Systematic Review of Screening and diagnostic Tests. Recommended methods [updated 6 Jun 1996]. Available at: http://www.cochrane.org/docs/sadtdoc1.htm. Retrieved October 5, 2004.
13. Khan KS, Dinnes J, Kleijnen J. Systematic reviews to evaluate diagnostic tests. Eur J Obstet Gynecol Reprod Biol 2001;95:6-11.
14. Decks JJ. Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests [review]. BMJ 2001;323:157-62.
15. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative [review]. BMJ 2003;326:41-4.
16. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, et al. Empirical evidence of design-related bias in studies of diagnostic tests [published erratum appears in JAMA 2000;283:1963]. JAMA 1999;282:1061-6.
17. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, et al. Empirical evidence of design-related bias in studies of diagnostic tests [published erratum appears in JAMA 2000;283:1963]. JAMA 1999;282:1061-6.
18. Walter SD, Cook RJ. A comparison of several point estimators of the odds ratio in a single 2 × 2 contingency table. Biometrics 1991;47:795-811.
19. Higgins JP, Thompson SG, Decks JJ, Altman DG. Measuring inconsistency in meta-analyses [review]. BMJ 2003;327:557-60.
20. Villar J, Mackey ME, Carroli G, Donner A. Meta-analyses in systematic reviews of randomized controlled trials in perinatal medicine: comparison of fixed and random effects models. Stat Med 2001;20:3635-47.
21. Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med 2001;20:2865-84.
22. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analyses detected by a simple graphical test. BMJ 1997;315:629-34.
23. Steel SA, Pearce JM, McParland P, Chamberlain GV. Early Doppler ultrasound screening in prediction of hypertensive disorders of pregnancy. Lancet 1990;335:1548-51.
24. Bewley S, Cooper D, Campbell S. Doppler investigation of uteroplacental blood flow resistance in the second trimester: a screening study for preeclampsia and intra-uterine growth retardation. Br J Obstet Gynaecol 1991;98:871-9.
25. Bower S, Bewley S, Campbell S. Improved prediction of preeclampsia by two-stage screening of uterine arteries using the early diastolic notch and color Doppler imaging. Obstet Gynecol 1993;82:78-83.
26. Bower S, Schuchter K, Campbell S. Doppler ultrasound screening as part of routine antenatal scanning: prediction of preeclampsia and intrauterine growth retardation. Br J Obstet Gynaecol 1993;100:989-94.
27. Valensise H, Bezzeccheri V, Rizzo G, Tranquilli AL, Garzetri GG, Romanini C. Doppler velocimetry of the uterine artery as a screening test for gestarional hypertension. Ultrasound Obstet Gynecol 1993;3:18-22.
28. Atkinson MW, Maher JE, Owen J, Hauth JC, Goldenberg RL, Copper RL. The predictive value of umbilical artery Doppler studies for preeclampsia or fetal growth retardation in a preeclampsia prevention trial. Obstet Gynecol 1994;83:609-12.
29. North RA, Ferrier C, Long D, Townend K, Kincaid-Smith P. Uterine artery Doppler flow velocity waveforms in the second trimester for the prediction of preeclampsia and fetal growth retardation. Obstet Gynecol 1994;83:378-86.
30. Sato H. A study for predicting toxemia of pregnancy by the diastolic notch in pulsed Doppler flow velocity waveforms of the uterine arteries-quantitative analysis of the diastolic notch as uterine arterial index (UTAI) [in Japanese]. Nippon Sanka Fujinka Gakkai Zasshi 1995;47:1055-62.
31. Harrington K, Cooper D, Lees C, Hecher K, Campbell S. Doppler ultrasound of the uterine arteries: the importance of bilateral notching in the prediction of preeclampsia, placental abruption or delivery of a small-for-gestational-age baby. Ultrasound Obstet Gynecol 1996;7:182-8.
32. Morris JM, Fay RA, Ellwood DA, Cook CM, Devonald KJ. A Randomized controlled trial of aspirin in patients with abnormal uterine artery blood flow. Obstet Gynecol 1996;87:74-8.
33. Frusca T, Soregaroli M, Valcamonico A, Guandalini F, Danti L. Doppler velocimetry of the uterine arteries in nulliparous women. Early Hum Dev 1997;25:177-85.
34. Harrington K, Carpenter RG, Goldfrad C, Campbell S. Transvaginal Doppler ultrasound of the uteroplacental circulation in the early prediction of preeclampsia and intrauterine growth retardation. Br J Obstet Gynaecol 1997;104:674-81.
35. Irion O, Masse J, Forest JC, Moutquin JM. Prediction of preeclampsia, low birthweight for gestation and prematurity by uterine artery blood flow velocity waveforms analysis in low risk nulliparous women. Br J Obstet Gynaecol 1998;105:422-9.
36. Kurdi W, Campbell S, Aquilina J, England P, Harrington K. The role of color Doppler imaging of the uterine arteries at 20 weeks' gestation in stratifying antenatal care. Ultrasound Obstet Gynecol 1998;12:339-45.
37. Mires GJ, Williams FL, Leslie J, Howie PW. Assessment of uterine arterial notching as a screening test for adverse pregnancy outcome. Am J Obstet Gynecol 1998;179:1317-23.
38. Caforio L, Testa AC, Mastromarino C, Carducci B, Ciampelli M, Mansueto D, Caruso A. Predictive value of uterine artery velocimetry at midgestation in low- and high-risk populations: a new perspective. Fetal Diagn Ther 1999;14:201-5.
39. Aardema MW, De Wolf BT, Saro MC, Oosterhof H, Fidler V, Aarnoudse JG. Quantification of the diastolic notch in Doppler ultrasound screening of uterine arteries. Ultrasound Obstet Gynecol 2000;16:630-4.
40. Albaiges G, Missfelder-Lobos H, Lees C, Parra M, Nicolaides KH. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation. Obstet Gynecol 2000;96:559-64.
41. Antsaklis A, Daskalakis G, Tzortzis E, Michalas S. The effect of gestational age and placental location on the prediction of preeclampsia by uterine artery Doppler velocimetry in low-risk nulliparous women. Ultrasound Obstet Gynecol 2000;16:635-9.
42. Ohkuchi A, Minakami H, Sato I, Mori H, Nakano T, Tateno M. Predicting the risk of preeclampsia and a small-for-gestational-age infant by quantitative assessment of the diastolic notch in uterine artery flow velocity waveforms in unselected women. Ultrasound Obstet Gynecol 2000;16:171-8.
43. Tranquilli AL, Giannubilo SR, Bezzeccheri V, Garbati E. The relative weight of Doppler of the uterine artery and 24-h ambulatory blood pressure monitoring in predicting hypertension in pregnancy and preeclampsia [in Italian] Acta Biomed Ateneo Parmense 2000;71(Suppl 1):351-5.
44. Aquilina J, Thompson O, Thilaganathan B, Harrington K. Improved early prediction of preeclampsia by combining second-trimester maternal serum inhibin-A and uterine artery Doppler. Ultrasound Obstet Gynecol 2001;17:477-84.
45. Geipel A, Ludwig M, Germer U, Katalinic A, Diedrich K, Gembruch U. Uterine artery Doppler velocimetry and the outcome of pregnancies resulting from ICSI. Hum Reprod 2001;16:1397-402.
46. Martin AM, Bindra R, Curdo P, Cicero S, Nicolaides KH. Screening for preeclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 2001;18:583-6.
47. Papageorghiou AT, Yu CK, Bindra R, Pandis G, Nicolaides KH, for the Fetal Medicine Foundation Second Trimester Screening Group. Multicenter screening for preeclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol 2001;18:441-9.
48. Becker R, Vonk R, Vollert W, Entezami M. Doppler sonography of uterine arteries at 20-23 weeks: risk assessment of adverse pregnancy outcome by quantification of impedance and notch. J Perinat Med 2002;30:388-94.
49. Trudinger BJ, Giles WB, Cook CM. Uteroplacental blood flow velocity-time waveforms in normal and complicated pregnancy. Br J Obstet Gynaecol 1985;92:39-45.
50. Arduini D, Rizzo G, Romanini C, Mancuso S. Utero-placental-blood flow velocity waveforms as predictors of pregnancy-induced hypertension. Eur J Obstet Gynecol Reprod Biol 1987;26:335-41.
51. Jacobson SL, Imhof R, Manning N, Mannion V, Little D, Rey E, Redman C. The value of Doppler assessment of the uteroplacental circulation in predicting preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 1990;162:110-4.
52. Pattinson RC, Brink AL, De Wet PE, Odendaal HJ. Early detection of poor fetal prognosis by serial Doppler velocimetry in high-risk pregnancies. S Afr Med J 1991;80:428-31.
53. Benifla JL, Tchobroutsky C, Uzan M, Sultan Y, Weill BJ, Laumond-Barny S. Predictive value of uterine artery velocity waveforms in pregnancies complicated by systemic lupus erythematosus and the antiphospholipid syndrome. Fetal Diagn Ther 1992;7:195-202.
54. Guzman E, Schulman H, Bracero L, Rochelson B, Farmakides G, Coury A. Uterine-umbilical artery Doppler velocimetry in pregnant women with systemic lupus erythematosus. J Ultrasound Med 1992;11:275-81.
55. Caruso A, De Carolis S, Ferrazzani S, Valesini G, Caforio L, Mancuso S. Pregnancy outcome in relation to uterine artery flow velocity waveforms and clinical characteristics in women with antiphospholipid syndrome. Obstet Gynecol 1993;82:970-7.
56. Haddad B, Uzan M, Tchobroutsky C, Uzan S, Papiernik-Berkhauer E. Predictive value of uterine Doppler waveform during pregnancies complicated by diabetes. Fetal Diagn Ther 1993;8:119-25.
57. Rizzo G, Arduini D, Romanini C. Uterine artery Doppler velocity waveforms in twin pregnancies. Obstet Gynecol 1993;82:978-83.
58. Ferrier C, North RA, Becker G, Cincotta R, Fairley K, Kincaid-Smith P. Uterine artery waveform as a predictor of pregnancy outcome in women with underlying renal disease. Clin Nephrol 1994;42:362-8.
59. Chan FY, Pun TC, Lam C, Khoo J, Lee CP, Lam YH. Pregnancy screening by uterine artery Doppler velocimetry-which criterion performs best? Obstet Gynecol 1995;85:596-602.
60. Haddad B, Uzan M, Breart G, Uzan S. Uterine Doppler wave form and the prediction of the recurrence of preeclampsia and intra-uterine growth retardation in patients treated with low-dose aspirin. Eur J Obstet Gynecol Reprod Biol 1995;62:179-83.
61. Konchak PS, Bernstein IM, Capeless EL. Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels. Am J Obstet Gynecol 1995;173:1115-9.
62. Frusca T, Soregaroli M, Zanelli S, Danti L, Guandalini F, Valcamonico A. Role of uterine artery Doppler investigation in pregnant women with chronic hypertension. Eur J Obstet Gynecol Reprod Biol 1998;79:47-50.
63. Aardema MW, Lander M, Oosterhof H, De Wolf BT, Aarnoudse JG. Doppler ultrasound screening predicts recurrence of poor pregnancy outcome in subsequent pregnancies, but not the recurrence of PIH or preeclampsia. Hypertens Pregnancy 2000;19:281-8.
64. Chung JE, Cho JS, Han SS, Park YW, Kim JW. Uterine artery Doppler velocimetry in the prediction of adverse obstetric outcomes in unexplained MSAFP elevations. Yonsei Med J 2000;41:17-21.
65. Coleman MA, McCowan LM, North RA. Mid-trimester uterine artery Doppler screening as a predictor of adverse pregnancy outcome in high-risk women. Ultrasound Obstet Gynecol 2000;15:7-12.
66. Venkat-Raman N, Backos M, Teoh TG, Lo WT, Regan L. Uterine artery Doppler in predicting pregnancy outcome in women with antiphospholipid syndrome. Obstet Gynecol 2001;98:235-42.
67. Geipel A, Berg C, Germer U, Katalinic A, Krapp M, Smrcek J, Gembruch U. Doppler assessment of the uterine circulation in the second trimester in twin pregnancies: prediction of preeclampsia, fetal growth restriction and birth weight discordance. Ultrasound Obstet Gynecol 2002;20:541-5.
68. Higgins JR, Walshe JJ, Halligan A, O'Brien E, Conroy R, Darling MR. Can 24-hour ambulatory blood pressure measurement predict the development of hypertension in primigravidae? [published erratum appears in Br J Obstet Gynaecol 1997;104:974] Br J Obstet Gynaecol 1997;104:356-62.
69. Higgins JR, Walshe JJ, Halligan A, O'Brien E, Conroy R, Darling MR. Can 24-hour ambulatory blood pressure measurement predict the development of hypertension in primigravidae? [published erratum appears in Br J Obstet Gynaecol 1997;104:974] Br J Obstet Gynaecol 1997;104:356-62.
70. Lauszus FF, Rasmussen OW, Lousen T, Klebe TM, Klebe JG. Ambulatory blood pressure as predictor of preeclampsia in diabetic pregnancies with respect to urinary albumin excretion rate and glycemic regulation. Acta Obstet Gynecol Scand 2001;80:1096-103.
71. Muller F, Savey L, Le Fiblec B, Bussieres L, Ndayizamba G, Colau JC, et al. Maternal serum human chorionic gonadotropin level at fifteen weeks is a predictor for preeclampsia. Am J Obstet Gynecol 1996;175:37-40.
72. Vaillant P, David E, Constant I, Athmani B, Devulder G, Fievet P, et al. Validity in nulliparas of increased beta-human chorionic gonadotrophin at mid-term for predicting pregnancy-induced hypertension complicated with proteinuria and intrauterine growth retardation. Nephron 1996;72:557-63.
73. Ashour AM, Lieberman ES, Haug LE, Repke JT. The value of elevated second-trimester beta-human chorionic gonadotropin in predicting development of preeclampsia. Am J Obstet Gynecol 1997;176:438-42.
74. Morssink LP, Heringa MP, Beekhuis JR, De Wolf BT, Mantingh A. The association between hypertensive disorders of pregnancy and abnormal second-trimester maternal serum levels of hCG and alpha-fetoprotein. Obstet Gynecol 1997;89:666-70.
75. Onderoglu LS, Kabukcu A. Elevated second trimester human chorionic gonadotropin level associated with adverse pregnancy outcome. Int J Gynaecol Obstet 1997;56:245-9.
76. Luckas M, Hawe J, Meekins J, Neilson J, Walkinshaw S. Second trimester serum free beta human chorionic gonadotrophin levels as a predictor of preeclampsia. Acta Obstet Gynecol Scand 1998;77:381-4.
77. Pouta AM, Hartikainen AL, Vuolteenaho QJ, Ruokonen AO, Laatikainen TJ. Midtrimester N-terminal proatrial natriuretic peptide, free beta hCG, and alpha-fetoprotein in predicting preeclampsia. Obstet Gynecol 1998;91:940-4.
78. Yaron Y, Cherry M, Kramer RL, O'Brien JE, Hallak M, Johnson MP, Evans MI. Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome. Am J Obstet Gynecol 1999;181:968-74.
79. Aquilina J, Maplethorpe R, Ellis P, Harrington K. Correlation between second trimester maternal serum inhibin-A and human chorionic gonadotrophin for the prediction of preeclampsia. Placenta 2000;21:487-92.
80. Stamilio DM, Sehdev HM, Morgan MA, Propert K, Macones GA. Can antenatal clinical and biochemical markers predict the development of severe preeclampsia? Am J Obstet Gynecol 2000;182:589-94.
81. Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. Early pregnancy levels of pregnancy-associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 2002;87:1762-7.
82. Milunsky A, Jick SS, Bruell CL, MacLaughlin DS, Tsung YK, Jick H, et al. Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data. Am J Obstet Gynecol 1989;161:291-7.
83. Simpson JL, Palomaki GE, Mercer B, Haddow JE, Andersen R, Sibai B, et al. Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum α-alpha-fetoprotein measurements. Am J Obstet Gynecol 1995;173:1742-8.
84. Waller DK, Lustig LS, Cunningham GC, Feuchtbaum LB, Hook EB. The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications. Obstet Gynecol 1996;88:816-22.
85. Wenstrom KD, Owen J, Davis RO, Brumfield CG. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein. Obstet Gynecol 1996;87:213-6.
86. Leung TN, Chung TK, Madsen G, Lam CW, Lam PK, Walters WA, et al. Analysis of mid-trimester corricotrophin-releasing hormone and alpha-fetoprotein concentrations for predicting preeclampsia. Hum Reprod 2000;15:1813-8.
87. Sebire NJ, Roberts L, Noble P, Wallace E, Nicolaides KH. Raised maternal serum inhibin A concentration at 10 to 14 weeks of gestation is associated with preeclampsia. BJOG 2000;107:795-7.
88. Yaron Y, Heifetz S, Ochshorn Y, Lehavi O, Orr-Urtreger A. Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome. Prenat Diagn 2002;22:778-82.
89. Florio P, Reis FM, Pezzani I, Luisi S, Severi FM, Petraglia F. The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of preeclampsia. Ultrasound Obstet Gynecol 2003;21:165-9.
90. Zeeman GG, Alexander JM, McIntire DD, Byrd W, Leveno KJ. Inhibin-A and superimposed preeclampsia in women with chronic hypertension. Obstet Gynecol 2003;101:232-6.
91. Blackburn CA, Keelan JA, Taylor RS, North RA. Maternal serum activin A is not elevated before preeclampsia in women who are at high risk. Am J Obstet Gynecol 2003;188:807-11.
92. Rodriguez MH, Masaki DI, Mestman J, Kumar D, Rude R. Calcium/creatinine ratio and microalbuminuria in the prediction of preeclampsia. Am J Obstet Gynecol 1988;159:1452-5.
93. Sanchez-Ramos L, Jones DC, Cullen MT. Urinary calcium as an early marker for preeclampsia. Obstet Gynecol 1991;77:685-8.
94. Baker PN, Hackett GA. The use of urinary albumin-creatinine ratios and calcium-creatinine ratios as screening tests for pregnancy-induced hypertension. Obstet Gynecol 1994;83:745-9.
95. Conde-Agudelo A, Belizan JM, Lede R, Bergel E. Prediction of hypertensive disorders of pregnancy by calcium/creatinine ratio and other laboratory tests. Int J Gynecol Obstet 1994;47:285-6.
96. Jacob M, Wilfred G, Kangasabapathy AS, Balasubramanium N. Calcium creatinine ratio (CCR) in the prediction of preeclampsia. Aust N Z J Obstet Gynaecol 1995;35:113.
97. Ozcan T, Kaleli B, Ozeren M, Turan C, Zorlu G. Urinary calcium to creatinine ratio for predicting preeclampsia. Am J Perinatol 1995;12:349-51.
98. Suarez VR, Trelles JG, Miyahira JM. Urinary calcium in asymptomatic primigravidas who later developed preeclampsia. Obstet Gynecol 1996;87:79-82.
99. Izumi A, Minakami H, Kuwata T, Sato I. Calcium-to-creatinine ratio in spot urine samples in early pregnancy and its relation to the development of preeclampsia. Metabolism 1997;46:1107-8.
100. Kazerooni T, Hamze-Nejadi S. Calcium to creatinine ratio in a spot sample of urine for early prediction of preeclampsia. Int J Gynecol Obstet 2003;80:279-83.
101. Kyle PM, Campbell S, Buckley D, Kissane J, de Swiet M, Albano J, et al. A comparison of the inactive urinary kallikrein:creatinine ratio and the angiotensin sensitivity test for the prediction of preeclampsia. Br J Obstet Gynaecol 1996;103:981-7.
102. Millar JG, Campbell SK, Albano JD, Higgins BR, Clark AD. Early prediction of preeclampsia by measurement of kallikrein and creatinine on a random urine sample. Br J Obstet Gynaecol 1996;103:421-6.
103. Shaarawy M, Salem ME. The clinical value of micro-transferrinuria and microalbuminuria in the prediction of preeclampsia. Clin Chem Lab Med 2001;39:29-34.
104. Jacob M, Wilfred G, Kanagasabapathy AS, Balasubramaniam N. Urinary N-acetyl-beta-D-glucosaminidase in the prediction of preeclampsia and pregnancy-induced hypertension. Aust N Z J Obstet Gynaecol 1993;33:395-7.
105. Dreyfus M, Baldauf JJ, Ritter J, Van Cauwenberg JR, Hardy A, Foidart JM. The prediction of preeclampsia: reassessment of clinical value of increased plasma levels of fibronectin. Eur J Obstet Gynecol Reprod Biol 1998;78:25-8.
106. Murakami S, Matsubara N, Saitoh M, Miyakaw S, Shoji M, Kubo T. The relation between plasma homocysteine concentration and methylenetetrahydrofolate reductase gene polymorphism in pregnant women. J Obstet Gynaecol Res 2001;27:349-52.
107. Stuart RA, Kornman LH, McHugh NJ. A prospective study of pregnancy outcome in women screened at a routine antenatal clinic for anticardiolipin antibodies. Br J Obstet Gynaecol 1993;100:599-600.
108. Yasuda M, Takakuwa K, Tokunaga A, Tanaka K. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol 1995;86:555-9.
109. Katano K, Aoki A, Sasa H, Ogasawara M, Matsuura E, Yagami Y. beta 2-Glycoprotein I-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women. Hum Reprod 1996;11:509-12.
110. Faden D, Tincani A, Tanzi P, Spatola L, Lojacono A, Tarantini M, et al. Anti-beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-beta2 glycoprotein I antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia. Eur J Obstet Gynecol Reprod Biol 1997;73:37-42.
111. Konijnenberg A, van der Post JA, Mol BW, Schaap MC, Lazarov R, Bleker OP, et al. Can flow cytometric detection of platelet activation early in pregnancy predict the occurrence of preeclampsia? A prospective study. Am J Obstet Gynecol 1997;177:434-42.
112. Branch DW, Porter TF, Rittenhouse L, Caritis S, Sibai B, Hogg B, et al, for the National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Antiphospholipid antibodies in women at risk for preeclampsia. Am J Obstet Gynecol 2001;184:825-32; discussion 8324.
113. Lijmer JG, Bossuyt PM, Heisterkamp SH. Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat Med 2002;21:1525-37.
114. Goffinet F, Aboulker D, Paris-Llado J, Bucourt M, Uzan M, Papiernik E, et al. Screening with a uterine Doppler in low risk pregnant women followed by low dose aspirin in women with abnormal results: a multicenter randomised controlled trial. BJOG 2001;108:510-8.
115. Subtil D, Goeusse P, Houfflin-Debarge V, Puech F, Lequien P, Breart G, et al, for the Essai Régional Aspirine MÃr̈e-Enfant (ERASME) Collaborative Group. Randomised comparison of uterine artery Doppler and aspirin (100 mg) with placebo in nulliparous women: the Essai Régional Aspirin Mère-Enfant study (Part 2). BJOG 2003;110:485-91.
116. Chappell LC, Seed PT, Briley A, Kelly FJ, Hunt BJ, Charnock-Jones DS, et al. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 2002;187:127-36.
117. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672-83.
118. Thadhani R, Mutter WP, Wolf M, Levine RJ, Taylor RN, Sukhatme VP, et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 2004;89:770-5.
119. Villar J, Say L, Shennan A, Lindheimer M, Duley L, Conde-Agudelo A, et al. Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of pre-eclampsia and eclampsia [review]. Int J Gynaecol Obstet. 2004;85(Suppl 1):S28-41.